ID   GSTP1_HUMAN             Reviewed;         210 AA.
AC   P09211; O00460; Q15690; Q5TZY3;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 207.
DE   RecName: Full=Glutathione S-transferase P;
DE            EC=2.5.1.18;
DE   AltName: Full=GST class-pi;
DE   AltName: Full=GSTP1-1;
GN   Name=GSTP1; Synonyms=FAEES3, GST3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3664469;
RA   Kano T., Sakai M., Muramatsu M.;
RT   "Structure and expression of a human class pi glutathione S-
RT   transferase messenger RNA.";
RL   Cancer Res. 47:5626-5630(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3196325; DOI=10.1042/bj2550079;
RA   Cowell I.G., Dixon K.H., Pemble S.E., Ketterer B., Taylor J.B.;
RT   "The structure of the human glutathione S-transferase pi gene.";
RL   Biochem. J. 255:79-83(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2542132; DOI=10.1016/0378-1119(89)90377-6;
RA   Morrow C.S., Cowan K.H., Goldsmith M.E.;
RT   "Structure of the human genomic glutathione S-transferase-pi gene.";
RL   Gene 75:3-11(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2466554;
RA   Moscow J.A., Fairchild C.R., Madden M.J., Ransom D.T., Wieand H.S.,
RA   O'Brien E.E., Poplack D.G., Cossman J., Myers C.E., Cowan K.H.;
RT   "Expression of anionic glutathione-S-transferase and P-glycoprotein
RT   genes in human tissues and tumors.";
RL   Cancer Res. 49:1422-1428(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Bora P.S., Smith C., Lange L.G., Bora N.S., Jones C., Gerhard D.S.;
RT   "Human fatty acid ethyl ester synthase III gene: genomic organization,
RT   nucleotide sequence, genetic and chromosomal sublocalization.";
RL   Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS VAL-105 AND VAL-114.
RX   PubMed=9092542; DOI=10.1074/jbc.272.15.10004;
RA   Ali-Osman F., Akande O., Antoun G., Mao J.X., Buolamwini J.;
RT   "Molecular cloning, characterization, and expression in Escherichia
RT   coli of full-length cDNAs of three human glutathione S-transferase Pi
RT   gene variants. Evidence for differential catalytic activity of the
RT   encoded proteins.";
RL   J. Biol. Chem. 272:10004-10012(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS VAL-105 AND VAL-114.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-105.
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-24.
RX   PubMed=3979555; DOI=10.1016/0014-5793(85)80324-0;
RA   Alin P., Mannervik B., Joernvall H.;
RT   "Structural evidence for three different types of glutathione
RT   transferase in human tissues.";
RL   FEBS Lett. 182:319-322(1985).
RN   [12]
RP   PROTEIN SEQUENCE OF 2-24.
RX   PubMed=3864155; DOI=10.1073/pnas.82.21.7202;
RA   Mannervik B., Alin P., Guthenberg C., Jensson H., Tahir M.K.,
RA   Warholm M., Joernvall H.;
RT   "Identification of three classes of cytosolic glutathione transferase
RT   common to several mammalian species: correlation between structural
RT   data and enzymatic properties.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:7202-7206(1985).
RN   [13]
RP   PROTEIN SEQUENCE OF 2-14.
RX   PubMed=3395118; DOI=10.1016/0003-9861(88)90564-4;
RA   Singh S.V., Ahmad H., Kurosky A., Awasthi Y.C.;
RT   "Purification and characterization of unique glutathione S-
RT   transferases from human muscle.";
RL   Arch. Biochem. Biophys. 264:13-22(1988).
RN   [14]
RP   PROTEIN SEQUENCE OF 2-12.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [15]
RP   PROTEIN SEQUENCE OF 2-12; 20-71; 76-101; 104-141; 122-141 AND 192-209,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [16]
RP   PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9150948; DOI=10.1002/elps.1150180344;
RA   Ji H., Reid G.E., Moritz R.L., Eddes J.S., Burgess A.W., Simpson R.J.;
RT   "A two-dimensional gel database of human colon carcinoma proteins.";
RL   Electrophoresis 18:605-613(1997).
RN   [17]
RP   PRIMARY AND SECONDARY STRUCTURAL ANALYZES.
RX   PubMed=2327795; DOI=10.1016/0003-9861(90)90277-6;
RA   Ahmad H., Wilson D.E., Fritz R.R., Singh S.V., Medh R.D., Nagle G.T.,
RA   Awasthi Y.C., Kurosky A.;
RT   "Primary and secondary structural analyses of glutathione S-
RT   transferase pi from human placenta.";
RL   Arch. Biochem. Biophys. 278:398-408(1990).
RN   [18]
RP   CATALYTIC ACTIVITY, AND MUTAGENESIS OF TYR-8.
RX   PubMed=1567427; DOI=10.1016/0006-291X(92)91177-R;
RA   Kong K.H., Takasu K., Inoue H., Takahashi K.;
RT   "Tyrosine-7 in human class Pi glutathione S-transferase is important
RT   for lowering the pKa of the thiol group of glutathione in the enzyme-
RT   glutathione complex.";
RL   Biochem. Biophys. Res. Commun. 184:194-197(1992).
RN   [19]
RP   CATALYTIC ACTIVITY, AND MUTAGENESIS OF TYR-8.
RX   PubMed=1540159; DOI=10.1016/0006-291X(92)91848-K;
RA   Kong K.H., Nishida M., Inoue H., Takahashi K.;
RT   "Tyrosine-7 is an essential residue for the catalytic activity of
RT   human class PI glutathione S-transferase: chemical modification and
RT   site-directed mutagenesis studies.";
RL   Biochem. Biophys. Res. Commun. 182:1122-1129(1992).
RN   [20]
RP   MUTAGENESIS OF ASP-99, AND CATALYTIC ACTIVITY.
RX   PubMed=8433974; DOI=10.1093/protein/6.1.93;
RA   Kong K.-H., Inoue H., Takahashi K.;
RT   "Site-directed mutagenesis study on the roles of evolutionally
RT   conserved aspartic acid residues in human glutathione S-transferase
RT   P1-1.";
RL   Protein Eng. 6:93-99(1993).
RN   [21]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19269317; DOI=10.1016/j.freeradbiomed.2009.02.025;
RA   Goto S., Kawakatsu M., Izumi S., Urata Y., Kageyama K., Ihara Y.,
RA   Koji T., Kondo T.;
RT   "Glutathione S-transferase pi localizes in mitochondria and protects
RT   against oxidative stress.";
RL   Free Radic. Biol. Med. 46:1392-1403(2009).
RN   [22]
RP   PHOSPHORYLATION AT TYR-4 AND TYR-199.
RX   PubMed=19254954; DOI=10.1074/jbc.M808153200;
RA   Okamura T., Singh S., Buolamwini J., Haystead T., Friedman H.,
RA   Bigner D., Ali-Osman F.;
RT   "Tyrosine phosphorylation of the human glutathione S-transferase P1 by
RT   epidermal growth factor receptor.";
RL   J. Biol. Chem. 284:16979-16989(2009).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-128, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH CDK5.
RX   PubMed=21668448; DOI=10.1111/j.1471-4159.2011.07343.x;
RA   Sun K.H., Chang K.H., Clawson S., Ghosh S., Mirzaei H., Regnier F.,
RA   Shah K.;
RT   "Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase
RT   activity.";
RL   J. Neurochem. 118:902-914(2011).
RN   [26]
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-62, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) COMPLEX WITH S-HEXYLGLUTATHIONE.
RX   PubMed=1522586; DOI=10.1016/0022-2836(92)90692-D;
RA   Reinemer P., Dirr H.W., Ladenstein R., Huber R., Lo Bello M.,
RA   Federici G., Parker M.W.;
RT   "Three-dimensional structure of class pi glutathione S-transferase
RT   from human placenta in complex with S-hexylglutathione at 2.8-A
RT   resolution.";
RL   J. Mol. Biol. 227:214-226(1992).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH THE INHIBITOR
RP   ETHACRYNIC ACID AND GLUTATHIONE.
RX   PubMed=9012673; DOI=10.1021/bi962316i;
RA   Oakley A.J., Rossjohn J., Lo Bello M., Caccuri A.M., Federici G.,
RA   Parker M.W.;
RT   "The three-dimensional structure of the human Pi class glutathione
RT   transferase P1-1 in complex with the inhibitor ethacrynic acid and its
RT   glutathione conjugate.";
RL   Biochemistry 36:576-585(1997).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEXES WITH GLUTATHIONE
RP   AND INHIBITOR.
RX   PubMed=9245401; DOI=10.1021/bi970805s;
RA   Ji X., Tordova M., O'Donnell R., Parsons J.F., Hayden J.B.,
RA   Gilliland G.L., Zimniak P.;
RT   "Structure and function of the xenobiotic substrate-binding site and
RT   location of a potential non-substrate-binding site in a class pi
RT   glutathione S-transferase.";
RL   Biochemistry 36:9690-9702(1997).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEXES WITH GLUTATHIONE.
RX   PubMed=9398518; DOI=10.1006/jmbi.1997.1364;
RA   Oakley A.J., Lo Bello M., Battistoni A., Ricci G., Rossjohn J.,
RA   Villar H.O., Parker M.W.;
RT   "The structures of human glutathione transferase P1-1 in complex with
RT   glutathione and various inhibitors at high resolution.";
RL   J. Mol. Biol. 274:84-100(1997).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE.
RX   PubMed=9351803; DOI=10.1016/S0969-2126(97)00281-5;
RA   Prade L., Huber R., Manoharan T.H., Fahl W.E., Reuter W.;
RT   "Structures of class pi glutathione S-transferase from human placenta
RT   in complex with substrate, transition-state analogue and inhibitor.";
RL   Structure 5:1287-1295(1997).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS).
RX   PubMed=10441116; DOI=10.1021/bi990668u;
RA   Ji X., Blaszczyk J., Xiao B., O'Donnell R., Hu X., Herzog C.,
RA   Singh S.V., Zimniak P.;
RT   "Structure and function of residue 104 and water molecules in the
RT   xenobiotic substrate-binding site in human glutathione S-transferase
RT   P1-1.";
RL   Biochemistry 38:10231-10238(1999).
RN   [37]
RP   STRUCTURE BY NMR.
RX   PubMed=9485454; DOI=10.1021/bi971902o;
RA   Nicotra M., Paci M., Sette M., Oakley A.J., Parker M.W., Lo Bello M.,
RA   Caccuri A.M., Federici G., Ricci G.;
RT   "Solution structure of glutathione bound to human glutathione
RT   transferase P1-1: comparison of NMR measurements with the crystal
RT   structure.";
RL   Biochemistry 37:3020-3027(1998).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE.
RX   PubMed=19396894; DOI=10.1002/anie.200900185;
RA   Ang W.H., Parker L.J., De Luca A., Juillerat-Jeanneret L.,
RA   Morton C.J., Lo Bello M., Parker M.W., Dyson P.J.;
RT   "Rational design of an organometallic glutathione transferase
RT   inhibitor.";
RL   Angew. Chem. Int. Ed. 48:3854-3857(2009).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (1.53 ANGSTROMS) OF 2-210 IN COMPLEX WITH
RP   GLUTATHIONE.
RX   PubMed=19808963; DOI=10.1158/0008-5472.CAN-09-1314;
RA   Federici L., Lo Sterzo C., Pezzola S., Di Matteo A., Scaloni F.,
RA   Federici G., Caccuri A.M.;
RT   "Structural basis for the binding of the anticancer compound 6-(7-
RT   nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-
RT   transferases.";
RL   Cancer Res. 69:8025-8034(2009).
CC   -!- FUNCTION: Conjugation of reduced glutathione to a wide number of
CC       exogenous and endogenous hydrophobic electrophiles. Regulates
CC       negatively CDK5 activity via p25/p35 translocation to prevent
CC       neurodegeneration. {ECO:0000269|PubMed:21668448}.
CC   -!- CATALYTIC ACTIVITY: RX + glutathione = HX + R-S-glutathione.
CC       {ECO:0000269|PubMed:1540159, ECO:0000269|PubMed:1567427,
CC       ECO:0000269|PubMed:8433974}.
CC   -!- SUBUNIT: Homodimer. Interacts with CDK5.
CC       {ECO:0000269|PubMed:21668448, ECO:0000269|PubMed:9012673}.
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=5; IntAct=EBI-353467, EBI-743771;
CC       Q15323:KRT31; NbExp=5; IntAct=EBI-353467, EBI-948001;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-353467, EBI-10172290;
CC       P60411:KRTAP10-9; NbExp=3; IntAct=EBI-353467, EBI-10172052;
CC       Q7Z3S9:NOTCH2NL; NbExp=5; IntAct=EBI-353467, EBI-945833;
CC       P30041:PRDX6; NbExp=2; IntAct=EBI-353467, EBI-2255129;
CC       Q12933:TRAF2; NbExp=5; IntAct=EBI-353467, EBI-355744;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19269317}.
CC       Mitochondrion {ECO:0000269|PubMed:19269317}. Nucleus
CC       {ECO:0000269|PubMed:19269317}. Note=The 83 N-terminal amino acids
CC       function as un uncleaved transit peptide, and arginine residues
CC       within it are crucial for mitochondrial localization.
CC   -!- SIMILARITY: Belongs to the GST superfamily. Pi family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/gstp1/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=GSTP1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X06547; CAA29794.1; -; mRNA.
DR   EMBL; M24485; AAA56823.1; -; Genomic_DNA.
DR   EMBL; X08058; CAA30847.1; -; Genomic_DNA.
DR   EMBL; X08094; CAA30894.1; -; Genomic_DNA.
DR   EMBL; X08095; CAA30894.1; JOINED; Genomic_DNA.
DR   EMBL; X08096; CAA30894.1; JOINED; Genomic_DNA.
DR   EMBL; X15480; CAA33508.1; -; mRNA.
DR   EMBL; U12472; AAA64919.1; -; Genomic_DNA.
DR   EMBL; U30897; AAC51280.1; -; mRNA.
DR   EMBL; U62589; AAC51237.1; -; mRNA.
DR   EMBL; U21689; AAC13869.1; -; Genomic_DNA.
DR   EMBL; BT019949; AAV38752.1; -; mRNA.
DR   EMBL; BT019950; AAV38753.1; -; mRNA.
DR   EMBL; CR450361; CAG29357.1; -; mRNA.
DR   EMBL; AY324387; AAP72967.1; -; Genomic_DNA.
DR   EMBL; BC010915; AAH10915.1; -; mRNA.
DR   CCDS; CCDS41679.1; -.
DR   PIR; A41177; A41177.
DR   PIR; JS0153; A37378.
DR   RefSeq; NP_000843.1; NM_000852.3.
DR   UniGene; Hs.523836; -.
DR   PDB; 10GS; X-ray; 2.20 A; A/B=2-210.
DR   PDB; 11GS; X-ray; 2.30 A; A/B=1-210.
DR   PDB; 12GS; X-ray; 2.10 A; A/B=1-210.
DR   PDB; 13GS; X-ray; 1.90 A; A/B=1-210.
DR   PDB; 14GS; X-ray; 2.80 A; A/B=1-210.
DR   PDB; 16GS; X-ray; 1.90 A; A/B=1-210.
DR   PDB; 17GS; X-ray; 1.90 A; A/B=1-210.
DR   PDB; 18GS; X-ray; 1.90 A; A/B=1-210.
DR   PDB; 19GS; X-ray; 1.90 A; A/B=2-210.
DR   PDB; 1AQV; X-ray; 1.94 A; A/B=2-210.
DR   PDB; 1AQW; X-ray; 1.80 A; A/B/C/D=2-210.
DR   PDB; 1AQX; X-ray; 2.00 A; A/B/C/D=2-210.
DR   PDB; 1EOG; X-ray; 2.10 A; A/B=3-210.
DR   PDB; 1EOH; X-ray; 2.50 A; A/B/C/D/E/F/G/H=2-210.
DR   PDB; 1GSS; X-ray; 2.80 A; A/B=2-210.
DR   PDB; 1KBN; X-ray; 2.00 A; A/B=2-210.
DR   PDB; 1LBK; X-ray; 1.86 A; A/B=2-203.
DR   PDB; 1MD3; X-ray; 2.03 A; A/B=2-210.
DR   PDB; 1MD4; X-ray; 2.10 A; A/B=2-210.
DR   PDB; 1PGT; X-ray; 1.80 A; A/B=1-210.
DR   PDB; 1PX6; X-ray; 2.10 A; A/B=2-210.
DR   PDB; 1PX7; X-ray; 2.03 A; A/B=2-210.
DR   PDB; 1ZGN; X-ray; 2.10 A; A/B=2-210.
DR   PDB; 20GS; X-ray; 2.45 A; A/B=2-210.
DR   PDB; 22GS; X-ray; 1.90 A; A/B=1-210.
DR   PDB; 2A2R; X-ray; 1.40 A; A/B=1-210.
DR   PDB; 2A2S; X-ray; 1.70 A; A/B=1-210.
DR   PDB; 2GSS; X-ray; 1.90 A; A/B=2-210.
DR   PDB; 2J9H; X-ray; 2.40 A; A/B=2-210.
DR   PDB; 2PGT; X-ray; 1.90 A; A/B=1-210.
DR   PDB; 3CSH; X-ray; 1.55 A; A/B=2-210.
DR   PDB; 3CSI; X-ray; 1.90 A; A/B/C/D=2-210.
DR   PDB; 3CSJ; X-ray; 1.90 A; A/B=2-210.
DR   PDB; 3DD3; X-ray; 2.25 A; A/B=1-210.
DR   PDB; 3DGQ; X-ray; 1.60 A; A/B=1-210.
DR   PDB; 3GSS; X-ray; 1.90 A; A/B=2-210.
DR   PDB; 3GUS; X-ray; 1.53 A; A/B=2-210.
DR   PDB; 3HJM; X-ray; 2.10 A; A/B/C/D=2-210.
DR   PDB; 3HJO; X-ray; 1.95 A; A/B=2-210.
DR   PDB; 3HKR; X-ray; 1.80 A; A/B=2-210.
DR   PDB; 3IE3; X-ray; 1.80 A; A/B=2-210.
DR   PDB; 3KM6; X-ray; 2.10 A; A/B=2-210.
DR   PDB; 3KMN; X-ray; 1.80 A; A/B=2-210.
DR   PDB; 3KMO; X-ray; 2.60 A; A/B=2-210.
DR   PDB; 3N9J; X-ray; 1.85 A; A/B=1-210.
DR   PDB; 3PGT; X-ray; 2.14 A; A/B=1-210.
DR   PDB; 4GSS; X-ray; 2.50 A; A/B=2-210.
DR   PDB; 4PGT; X-ray; 2.10 A; A/B=1-210.
DR   PDB; 5DAK; X-ray; 2.11 A; A/B=1-210.
DR   PDB; 5DAL; X-ray; 1.50 A; A/B=1-210.
DR   PDB; 5DCG; X-ray; 2.01 A; A/B=1-210.
DR   PDB; 5DDL; X-ray; 1.98 A; A/B=1-210.
DR   PDB; 5DJL; X-ray; 1.80 A; A/B=1-210.
DR   PDB; 5DJM; X-ray; 1.90 A; A/B=1-210.
DR   PDB; 5GSS; X-ray; 1.95 A; A/B=2-210.
DR   PDB; 5J41; X-ray; 1.19 A; A/B=2-210.
DR   PDB; 5JCW; X-ray; 1.95 A; A/B=1-210.
DR   PDB; 6GSS; X-ray; 1.90 A; A/B=2-210.
DR   PDB; 7GSS; X-ray; 2.20 A; A/B=2-210.
DR   PDB; 8GSS; X-ray; 1.90 A; A/B/C=2-210.
DR   PDB; 9GSS; X-ray; 1.97 A; A/B=2-210.
DR   PDBsum; 10GS; -.
DR   PDBsum; 11GS; -.
DR   PDBsum; 12GS; -.
DR   PDBsum; 13GS; -.
DR   PDBsum; 14GS; -.
DR   PDBsum; 16GS; -.
DR   PDBsum; 17GS; -.
DR   PDBsum; 18GS; -.
DR   PDBsum; 19GS; -.
DR   PDBsum; 1AQV; -.
DR   PDBsum; 1AQW; -.
DR   PDBsum; 1AQX; -.
DR   PDBsum; 1EOG; -.
DR   PDBsum; 1EOH; -.
DR   PDBsum; 1GSS; -.
DR   PDBsum; 1KBN; -.
DR   PDBsum; 1LBK; -.
DR   PDBsum; 1MD3; -.
DR   PDBsum; 1MD4; -.
DR   PDBsum; 1PGT; -.
DR   PDBsum; 1PX6; -.
DR   PDBsum; 1PX7; -.
DR   PDBsum; 1ZGN; -.
DR   PDBsum; 20GS; -.
DR   PDBsum; 22GS; -.
DR   PDBsum; 2A2R; -.
DR   PDBsum; 2A2S; -.
DR   PDBsum; 2GSS; -.
DR   PDBsum; 2J9H; -.
DR   PDBsum; 2PGT; -.
DR   PDBsum; 3CSH; -.
DR   PDBsum; 3CSI; -.
DR   PDBsum; 3CSJ; -.
DR   PDBsum; 3DD3; -.
DR   PDBsum; 3DGQ; -.
DR   PDBsum; 3GSS; -.
DR   PDBsum; 3GUS; -.
DR   PDBsum; 3HJM; -.
DR   PDBsum; 3HJO; -.
DR   PDBsum; 3HKR; -.
DR   PDBsum; 3IE3; -.
DR   PDBsum; 3KM6; -.
DR   PDBsum; 3KMN; -.
DR   PDBsum; 3KMO; -.
DR   PDBsum; 3N9J; -.
DR   PDBsum; 3PGT; -.
DR   PDBsum; 4GSS; -.
DR   PDBsum; 4PGT; -.
DR   PDBsum; 5DAK; -.
DR   PDBsum; 5DAL; -.
DR   PDBsum; 5DCG; -.
DR   PDBsum; 5DDL; -.
DR   PDBsum; 5DJL; -.
DR   PDBsum; 5DJM; -.
DR   PDBsum; 5GSS; -.
DR   PDBsum; 5J41; -.
DR   PDBsum; 5JCW; -.
DR   PDBsum; 6GSS; -.
DR   PDBsum; 7GSS; -.
DR   PDBsum; 8GSS; -.
DR   PDBsum; 9GSS; -.
DR   ProteinModelPortal; P09211; -.
DR   SMR; P09211; -.
DR   BioGrid; 109205; 46.
DR   IntAct; P09211; 55.
DR   MINT; MINT-4998983; -.
DR   STRING; 9606.ENSP00000381607; -.
DR   BindingDB; P09211; -.
DR   ChEMBL; CHEMBL3902; -.
DR   DrugBank; DB03814; 2-(N-Morpholino)-Ethanesulfonic Acid.
DR   DrugBank; DB01008; Busulfan.
DR   DrugBank; DB04972; Canfosfamide.
DR   DrugBank; DB04339; Carbocisteine.
DR   DrugBank; DB00958; Carboplatin.
DR   DrugBank; DB00291; Chlorambucil.
DR   DrugBank; DB02633; Cibacron Blue.
DR   DrugBank; DB00515; Cisplatin.
DR   DrugBank; DB01242; Clomipramine.
DR   DrugBank; DB00773; Etoposide.
DR   DrugBank; DB00143; Glutathione.
DR   DrugBank; DB03003; Glutathione Sulfonic Acid.
DR   DrugBank; DB04077; Glycerol.
DR   DrugBank; DB00526; Oxaliplatin.
DR   DrugBank; DB08370; S-(4-BROMOBENZYL)CYSTEINE.
DR   DrugBank; DB03686; S-(P-Nitrobenzyl)Glutathione.
DR   DrugBank; DB04132; S-Hexylglutathione.
DR   DrugBank; DB01915; S-Hydroxycysteine.
DR   DrugBank; DB07849; S-NONYL-CYSTEINE.
DR   DrugBank; DB05460; TLK-199.
DR   DrugBank; DB00163; Vitamin E.
DR   SwissLipids; SLP:000001615; -.
DR   iPTMnet; P09211; -.
DR   PhosphoSitePlus; P09211; -.
DR   SwissPalm; P09211; -.
DR   BioMuta; GSTP1; -.
DR   DOSAC-COBS-2DPAGE; P09211; -.
DR   OGP; P09211; -.
DR   REPRODUCTION-2DPAGE; IPI00219757; -.
DR   SWISS-2DPAGE; P09211; -.
DR   UCD-2DPAGE; P09211; -.
DR   EPD; P09211; -.
DR   PaxDb; P09211; -.
DR   PeptideAtlas; P09211; -.
DR   PRIDE; P09211; -.
DR   TopDownProteomics; P09211; -.
DR   DNASU; 2950; -.
DR   Ensembl; ENST00000398606; ENSP00000381607; ENSG00000084207.
DR   GeneID; 2950; -.
DR   KEGG; hsa:2950; -.
DR   CTD; 2950; -.
DR   DisGeNET; 2950; -.
DR   GeneCards; GSTP1; -.
DR   HGNC; HGNC:4638; GSTP1.
DR   HPA; HPA019779; -.
DR   HPA; HPA019869; -.
DR   MIM; 134660; gene.
DR   neXtProt; NX_P09211; -.
DR   OpenTargets; ENSG00000084207; -.
DR   PharmGKB; PA29028; -.
DR   eggNOG; KOG1695; Eukaryota.
DR   eggNOG; ENOG4111VAU; LUCA.
DR   GeneTree; ENSGT00550000074559; -.
DR   HOGENOM; HOG000115733; -.
DR   HOVERGEN; HBG108324; -.
DR   InParanoid; P09211; -.
DR   KO; K00799; -.
DR   OMA; LRCKYAT; -.
DR   OrthoDB; EOG091G0K2E; -.
DR   PhylomeDB; P09211; -.
DR   TreeFam; TF105321; -.
DR   BRENDA; 2.5.1.18; 2681.
DR   Reactome; R-HSA-156590; Glutathione conjugation.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SABIO-RK; P09211; -.
DR   SIGNOR; P09211; -.
DR   ChiTaRS; GSTP1; human.
DR   EvolutionaryTrace; P09211; -.
DR   GeneWiki; GSTP1; -.
DR   GenomeRNAi; 2950; -.
DR   PMAP-CutDB; P09211; -.
DR   PRO; PR:P09211; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000084207; -.
DR   CleanEx; HS_GSTP1; -.
DR   ExpressionAtlas; P09211; baseline and differential.
DR   Genevisible; P09211; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005622; C:intracellular; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0097057; C:TRAF2-GSTP1 complex; IDA:BHF-UCL.
DR   GO; GO:0031982; C:vesicle; IDA:UniProtKB.
DR   GO; GO:0035731; F:dinitrosyl-iron complex binding; IDA:BHF-UCL.
DR   GO; GO:0008144; F:drug binding; IEA:Ensembl.
DR   GO; GO:0043295; F:glutathione binding; IEA:Ensembl.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IDA:BHF-UCL.
DR   GO; GO:0004364; F:glutathione transferase activity; IDA:UniProtKB.
DR   GO; GO:0008432; F:JUN kinase binding; ISS:BHF-UCL.
DR   GO; GO:0019207; F:kinase regulator activity; ISS:BHF-UCL.
DR   GO; GO:0070026; F:nitric oxide binding; NAS:BHF-UCL.
DR   GO; GO:0035730; F:S-nitrosoglutathione binding; IDA:BHF-UCL.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0071460; P:cellular response to cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; IEA:Ensembl.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISS:BHF-UCL.
DR   GO; GO:0007417; P:central nervous system development; TAS:ProtInc.
DR   GO; GO:0035726; P:common myeloid progenitor cell proliferation; ISS:BHF-UCL.
DR   GO; GO:1901687; P:glutathione derivative biosynthetic process; TAS:Reactome.
DR   GO; GO:0006749; P:glutathione metabolic process; IDA:UniProtKB.
DR   GO; GO:0043651; P:linoleic acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0002674; P:negative regulation of acute inflammatory response; NAS:BHF-UCL.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0009890; P:negative regulation of biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; ISS:BHF-UCL.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; ISS:BHF-UCL.
DR   GO; GO:0032691; P:negative regulation of interleukin-1 beta production; IDA:BHF-UCL.
DR   GO; GO:0043508; P:negative regulation of JUN kinase activity; IDA:BHF-UCL.
DR   GO; GO:0070664; P:negative regulation of leukocyte proliferation; ISS:BHF-UCL.
DR   GO; GO:0043407; P:negative regulation of MAP kinase activity; IDA:BHF-UCL.
DR   GO; GO:0043409; P:negative regulation of MAPK cascade; NAS:BHF-UCL.
DR   GO; GO:0071638; P:negative regulation of monocyte chemotactic protein-1 production; IDA:BHF-UCL.
DR   GO; GO:0051771; P:negative regulation of nitric-oxide synthase biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0071672; P:negative regulation of smooth muscle cell chemotaxis; IEA:Ensembl.
DR   GO; GO:0032873; P:negative regulation of stress-activated MAPK cascade; ISS:BHF-UCL.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:BHF-UCL.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IC:BHF-UCL.
DR   GO; GO:1904706; P:negative regulation of vascular smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0035732; P:nitric oxide storage; NAS:BHF-UCL.
DR   GO; GO:0014003; P:oligodendrocyte development; IEA:Ensembl.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; ISS:BHF-UCL.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:BHF-UCL.
DR   GO; GO:0032872; P:regulation of stress-activated MAPK cascade; ISS:BHF-UCL.
DR   GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0033591; P:response to L-ascorbic acid; IEA:Ensembl.
DR   GO; GO:0000302; P:response to reactive oxygen species; ISS:BHF-UCL.
DR   GO; GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB.
DR   InterPro; IPR010987; Glutathione-S-Trfase_C-like.
DR   InterPro; IPR004045; Glutathione_S-Trfase_N.
DR   InterPro; IPR004046; GST_C.
DR   InterPro; IPR003082; GST_pi.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   Pfam; PF14497; GST_C_3; 1.
DR   Pfam; PF02798; GST_N; 1.
DR   PRINTS; PR01268; GSTRNSFRASEP.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS50405; GST_CTER; 1.
DR   PROSITE; PS50404; GST_NTER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Mitochondrion; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:3395118,
FT                                ECO:0000269|PubMed:3864155,
FT                                ECO:0000269|PubMed:3979555,
FT                                ECO:0000269|Ref.15}.
FT   CHAIN         2    210       Glutathione S-transferase P.
FT                                /FTId=PRO_0000185900.
FT   DOMAIN        2     81       GST N-terminal.
FT   DOMAIN       83    204       GST C-terminal.
FT   REGION       52     53       Glutathione binding.
FT                                {ECO:0000269|PubMed:1522586,
FT                                ECO:0000269|PubMed:19396894,
FT                                ECO:0000269|PubMed:19808963,
FT                                ECO:0000269|PubMed:9012673,
FT                                ECO:0000269|PubMed:9245401,
FT                                ECO:0000269|PubMed:9351803,
FT                                ECO:0000269|PubMed:9398518}.
FT   REGION       65     66       Glutathione binding.
FT                                {ECO:0000269|PubMed:1522586,
FT                                ECO:0000269|PubMed:19396894,
FT                                ECO:0000269|PubMed:19808963,
FT                                ECO:0000269|PubMed:9012673,
FT                                ECO:0000269|PubMed:9245401,
FT                                ECO:0000269|PubMed:9351803,
FT                                ECO:0000269|PubMed:9398518}.
FT   BINDING       8      8       Glutathione. {ECO:0000269|PubMed:1522586,
FT                                ECO:0000269|PubMed:19396894,
FT                                ECO:0000269|PubMed:19808963,
FT                                ECO:0000269|PubMed:9012673,
FT                                ECO:0000269|PubMed:9245401,
FT                                ECO:0000269|PubMed:9351803,
FT                                ECO:0000269|PubMed:9398518}.
FT   BINDING      14     14       Glutathione. {ECO:0000269|PubMed:1522586,
FT                                ECO:0000269|PubMed:19396894,
FT                                ECO:0000269|PubMed:19808963,
FT                                ECO:0000269|PubMed:9012673,
FT                                ECO:0000269|PubMed:9245401,
FT                                ECO:0000269|PubMed:9351803,
FT                                ECO:0000269|PubMed:9398518}.
FT   BINDING      39     39       Glutathione. {ECO:0000269|PubMed:1522586,
FT                                ECO:0000269|PubMed:19396894,
FT                                ECO:0000269|PubMed:19808963,
FT                                ECO:0000269|PubMed:9012673,
FT                                ECO:0000269|PubMed:9245401,
FT                                ECO:0000269|PubMed:9351803,
FT                                ECO:0000269|PubMed:9398518}.
FT   BINDING      45     45       Glutathione. {ECO:0000269|PubMed:1522586,
FT                                ECO:0000269|PubMed:19396894,
FT                                ECO:0000269|PubMed:19808963,
FT                                ECO:0000269|PubMed:9012673,
FT                                ECO:0000269|PubMed:9245401,
FT                                ECO:0000269|PubMed:9351803,
FT                                ECO:0000269|PubMed:9398518}.
FT   MOD_RES       4      4       Phosphotyrosine; by EGFR.
FT                                {ECO:0000269|PubMed:19254954}.
FT   MOD_RES      62     62       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     103    103       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P19157}.
FT   MOD_RES     116    116       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P19157}.
FT   MOD_RES     128    128       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     199    199       Phosphotyrosine; by EGFR.
FT                                {ECO:0000269|PubMed:19254954}.
FT   VARIANT     105    105       I -> V (in allele GSTP1*B and allele
FT                                GSTP1*C; dbSNP:rs1695).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9092542,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_014499.
FT   VARIANT     114    114       A -> V (in allele GSTP1*C;
FT                                dbSNP:rs1138272).
FT                                {ECO:0000269|PubMed:9092542,
FT                                ECO:0000269|Ref.9}.
FT                                /FTId=VAR_014500.
FT   VARIANT     169    169       G -> D (in dbSNP:rs41462048).
FT                                /FTId=VAR_049493.
FT   MUTAGEN       8      8       Y->F: Reduces catalytic activity about
FT                                50-fold. {ECO:0000269|PubMed:1540159,
FT                                ECO:0000269|PubMed:1567427}.
FT   MUTAGEN      99     99       D->A: Reduces affinity for glutathione.
FT                                Slightly reduced catalytic activity.
FT                                {ECO:0000269|PubMed:8433974}.
FT   CONFLICT    186    186       A -> P (in Ref. 2; CAA30894).
FT                                {ECO:0000305}.
FT   STRAND        4      8       {ECO:0000244|PDB:5J41}.
FT   STRAND       10     12       {ECO:0000244|PDB:5J41}.
FT   HELIX        13     15       {ECO:0000244|PDB:5J41}.
FT   HELIX        16     24       {ECO:0000244|PDB:5J41}.
FT   STRAND       29     33       {ECO:0000244|PDB:5J41}.
FT   HELIX        36     41       {ECO:0000244|PDB:5J41}.
FT   HELIX        43     47       {ECO:0000244|PDB:5J41}.
FT   STRAND       48     51       {ECO:0000244|PDB:3KMN}.
FT   STRAND       55     58       {ECO:0000244|PDB:5J41}.
FT   STRAND       61     65       {ECO:0000244|PDB:5J41}.
FT   HELIX        66     77       {ECO:0000244|PDB:5J41}.
FT   HELIX        84    110       {ECO:0000244|PDB:5J41}.
FT   HELIX       112    135       {ECO:0000244|PDB:5J41}.
FT   HELIX       138    140       {ECO:0000244|PDB:5J41}.
FT   STRAND      144    148       {ECO:0000244|PDB:5JCW}.
FT   HELIX       151    166       {ECO:0000244|PDB:5J41}.
FT   HELIX       170    173       {ECO:0000244|PDB:5J41}.
FT   HELIX       175    185       {ECO:0000244|PDB:5J41}.
FT   HELIX       188    195       {ECO:0000244|PDB:5J41}.
FT   HELIX       197    200       {ECO:0000244|PDB:5J41}.
FT   STRAND      204    208       {ECO:0000244|PDB:5J41}.
SQ   SEQUENCE   210 AA;  23356 MW;  409E33FFAA338396 CRC64;
     MPPYTVVYFP VRGRCAALRM LLADQGQSWK EEVVTVETWQ EGSLKASCLY GQLPKFQDGD
     LTLYQSNTIL RHLGRTLGLY GKDQQEAALV DMVNDGVEDL RCKYISLIYT NYEAGKDDYV
     KALPGQLKPF ETLLSQNQGG KTFIVGDQIS FADYNLLDLL LIHEVLAPGC LDAFPLLSAY
     VGRLSARPKL KAFLASPEYV NLPINGNGKQ
//
